B

Brainstorm Cell Therapeutics

D
BCLI
USD
-0.2
(-12.5786%)
Market Closed
4,522.00
Volume
-0.17
EPS
-
Div Yield
-6.318182
P/E
110,830,386.49
Market Cap
Today
-12.5786%
1 Week
-25.668%
1 Month
-37.104%
6 Months
-74.914%
12 Months
-45.650%
Year To Date
-66.019%
All Time
0%

Title:
Brainstorm Cell Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
Do you need help or have a question?